KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in Net LoansDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Omega Healthcare Investors (OHI) Short-Term Debt issuances (2016 - 2021)

Historic Short-Term Debt issuances for Omega Healthcare Investors (OHI) over the last 6 years, with Q1 2021 value amounting to $1.2 billion.

  • Omega Healthcare Investors' Short-Term Debt issuances rose 8265.09% to $1.2 billion in Q1 2021 from the same period last year, while for Mar 2021 it was $1.7 billion, marking a year-over-year decrease of 1433.43%. This contributed to the annual value of $1.2 billion for FY2020, which is 2272.95% down from last year.
  • Per Omega Healthcare Investors' latest filing, its Short-Term Debt issuances stood at $1.2 billion for Q1 2021, which was up 8265.09% from $225.0 million recorded in Q4 2020.
  • Omega Healthcare Investors' Short-Term Debt issuances' 5-year high stood at $1.2 billion during Q1 2021, with a 5-year trough of $100.0 million in Q2 2020.
  • Moreover, its 5-year median value for Short-Term Debt issuances was $288.0 million (2018), whereas its average is $403.5 million.
  • Within the past 5 years, the most significant YoY rise in Omega Healthcare Investors' Short-Term Debt issuances was 28740.7% (2020), while the steepest drop was 8039.22% (2020).
  • Over the past 5 years, Omega Healthcare Investors' Short-Term Debt issuances (Quarter) stood at $200.0 million in 2017, then soared by 44.0% to $288.0 million in 2018, then surged by 115.28% to $620.0 million in 2019, then plummeted by 63.71% to $225.0 million in 2020, then skyrocketed by 437.78% to $1.2 billion in 2021.
  • Its last three reported values are $1.2 billion in Q1 2021, $225.0 million for Q4 2020, and $177.0 million during Q3 2020.